Literature DB >> 8890786

High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.

C Nos, M Comabella, M Tintoré, J Rio, A Codina, X Montalban, A Rovira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890786      PMCID: PMC486589          DOI: 10.1136/jnnp.61.4.418-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  High-dose intravenous immunoglobulin for multiple sclerosis.

Authors:  J Yan; J R Richert; M D Sirdofsky
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

2.  High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.

Authors:  D H Miller; A J Thompson; S P Morrissey; D G MacManus; S G Moore; B E Kendall; I F Moseley; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-06       Impact factor: 10.154

3.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.

Authors:  N M Milligan; R Newcombe; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

4.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

5.  [Gamma globulin therapy in multiple sclerosis. Theoretical considerations and initial clinical experiences with 7S immunoglobulins in MS therapy].

Authors:  W Soukop; H Tschabitscher
Journal:  Wien Med Wochenschr       Date:  1986-09-30
  5 in total
  1 in total

1.  Neuromyelitis optica.

Authors:  Dean M Wingerchuk; Brian G Weinshenker
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.